Copyright
©The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Transplant. Mar 18, 2026; 16(1): 114592
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.114592
Published online Mar 18, 2026. doi: 10.5500/wjt.v16.i1.114592
Stem cell transplantation in immuno-hematologic and infectious diseases
Rhobi Peter Mwita, Department of Pediatrics, Sakarya University, Sakarya 54100, Türkiye
Öner Özdemir, Department of Pediatric Allergy and Immunology, Faculty of Medicine, Sakarya University, Adapazarı 54100, Sakarya, Türkiye
Author contributions: Mwita RP and Özdemir Ö contributed to the manuscript writing, revision, and approved the final manuscript publication.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Öner Özdemir, MD, Professor, Department of Pediatric Allergy and Immunology, Faculty of Medicine, Sakarya University, Sakarya Research and Training Hospital, Adnan Menderes Cad, Adapazarı 54100, Sakarya, Türkiye.
Received: September 24, 2025
Revised: October 24, 2025
Accepted: December 31, 2025
Published online: March 18, 2026
Processing time: 113 Days and 2 Hours
Revised: October 24, 2025
Accepted: December 31, 2025
Published online: March 18, 2026
Processing time: 113 Days and 2 Hours
Core Tip
Core Tip: Treatment of some diseases in the pediatric population can be ineffective with standard therapy. The use of stem cells to treat various diseases in this population has increased over the last few years due to technological and genetic advancements that have allowed more targeted therapies to be used. Ethical and legal issues remain a significant hindrance in research and clinical studies related to stem cells.